Hyperparathyroidism
📧 Sign up to get email alerts when something new happens for Hyperparathyroidism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients [Phase 4]
A Phase 4 pilot trial evaluated whether lowering parathyroid hormone reduces erythropoietin consumption in calcitriol-resistant patients wit…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Minimally Invasive Radioguided Parathyroidectomy
This clinical trial update reports the completion of a study evaluating minimally invasive radioguided parathyroidectomy for primary hyperpa…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy
A completed clinical trial sponsored by Benha University investigating how common secondary hyperparathyroidism is among patients with diabe…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
A pilot study evaluating hypovitaminosis D, hyperparathyroidism, and hypomagnesemia in congestive heart failure has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism [Phase 2]
Phase 2 study results for etelcalcetide in hemodialysis patients with secondary hyperparathyroidism, evaluating safety, tolerability and eff…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism [Phase 2]
Open-label Phase 2 trial assessing the long-term safety and efficacy of etelcalcetide in secondary hyperparathyroidism has been terminated. …
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder [Phase 2]
Phase 2 results update for etelcalcetide in treating secondary hyperparathyroidism in hemodialysis patients with CKD-MBD. Results were poste…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease [NA]
Clinical trial update on FGF-23 regulation in chronic kidney disease with results posted; focus on secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid [Phase 4]
Phase 4 clinical trial of REGPARA (cinacalcet) in dialysis patients with secondary hyperparathyroidism has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis [Phase 3]
Phase 3 trial assessing efficacy and safety of etelcalcetide (AMG 416) for secondary hyperparathyroidism in chronic kidney disease patients …
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Phase 3 Study of KHK7580 [Phase 2, Phase 3]
This update announces completion of the Phase 2/Phase 3 clinical trial of KHK7580 for secondary hyperparathyroidism.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery [Phase 3]
A Phase 3 trial evaluated paricalcitol plus cholecalciferol for secondary hyperparathyroidism in patients after Roux-en-Y gastric bypass; th…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism [Phase 3]
Phase 3 intra-individual titration trial evaluating KRN1493 for treating hypercalcemia in patients with parathyroid carcinoma or intractable…
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis [Phase 1, Phase 2]
A Phase 1/2 trial evaluating KHK7580 for secondary hyperparathyroidism in patients receiving hemodialysis has completed. The sponsor is Kyow…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism
This study evaluated whether the serum calcium to phosphorus ratio (Ca/P) can serve as a simple, inexpensive screening test to diagnose prim…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet [Phase 3]
Phase 3 head-to-head trial comparing etelcalcetide to cinacalcet in patients with secondary hyperparathyroidism and chronic kidney disease h…
-
CLINICAL_TRIALS trial_result · 2017-01-02Clinical Trial Update: Trial to Optimize Mineral Outcomes in Dialysis Patients [Phase 4]
Phase 4 clinical trial update evaluating mineral management in dialysis patients with secondary hyperparathyroidism; results have been poste…
-
CLINICAL_TRIALS trial_result · 2016-12-19Clinical Trial Update: Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease [Phase 1]
Phase 1 trial evaluating cinacalcet in children with chronic kidney disease completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-11-21Clinical Trial Update: A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis [Phase 3]
Phase 3 pediatric safety trial evaluating paricalcitol capsules in children aged 10 to 16 with Stage 5 chronic kidney disease on dialysis; t…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Intra-operative Infra-red Fluorescent Imaging in Thyroid and Parathyroid Surgery [Phase 1, Phase 2]
Clinical trial update on intra-operative infrared fluorescent imaging in thyroid and parathyroid surgery, with Phase 1 and Phase 2 completed…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Lipids Profile in Primary Hyperparathyroidism
The clinical trial investigating lipid profiles in primary hyperparathyroidism has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-08-25Clinical Trial Update: Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT) [Phase 2, Phase 3]
CTAP101 was evaluated in patients with chronic kidney disease and secondary hyperparathyroidism in Phase 2/3 safety and efficacy trials; the…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency [Phase 3]
A Phase 3 trial evaluating CTAP101 for secondary hyperparathyroidism in CKD Stage 3-4 with vitamin D insufficiency has completed. Results ha…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency [Phase 3]
This Phase 3 clinical trial reports safety and efficacy results for CTAP101 in treating secondary hyperparathyroidism in patients with stage…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002 [Phase 3]
OPKO Health's extension study of CTAP101-CL-3001 or CTAP101-CL-3002 has completed Phase 3 and posted results.